The trajectory of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the expiry in key regions has introduced considerable risk . Investors are now assessing the effect of generic competition , diminishi